Clopidogrel use in diabetic patients with new stents.
出版信息
Cardiovasc J Afr. 2008 Jul-Aug;19(4):232.
PMID:18776976
Abstract
摘要
相似文献
1
Clopidogrel use in diabetic patients with new stents.
Cardiovasc J Afr. 2008 Jul-Aug;19(4):232.
2
Off-label use and the spectre of drug-eluting stent thrombosis.
Circ Cardiovasc Interv. 2009 Aug;2(4):273-6. doi: 10.1161/CIRCINTERVENTIONS.109.891218.
3
Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
Thromb Haemost. 2008 Mar;99(3):637-9. doi: 10.1160/TH07-07-0465.
4
Noncardiac surgery after coronary stenting or angioplasty [corrected] .
Catheter Cardiovasc Interv. 2009 Nov 15;74(6):844-5. doi: 10.1002/ccd.22309.
5
Are we totally clear?
Catheter Cardiovasc Interv. 2009 Dec 1;74(7):987-8. doi: 10.1002/ccd.22335.
6
Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.
Circ Cardiovasc Interv. 2009 Dec;2(6):574-9. doi: 10.1161/CIRCINTERVENTIONS.109.871996.
7
Two-stent technique: a dead duck or alive and kicking?
Catheter Cardiovasc Interv. 2009 Aug 1;74(2):321-2. doi: 10.1002/ccd.22181.
8
Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Thromb Res. 2009 May;124(1):46-51. doi: 10.1016/j.thromres.2008.10.007. Epub 2008 Nov 28.
9
Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.
Am J Cardiol. 2008 Dec 15;102(12):1614-7. doi: 10.1016/j.amjcard.2008.07.063. Epub 2008 Sep 27.
10
Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int. 2009 Apr;18(100):70-4.
Zotero 插件